类药物合物,用于向HER2表达癌细胞的向输送
Amit Kumar Sharma1,2, Rohit Sharma1,2, Nitish Chauhan2,3
1Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.
概括
一种新的类药物合物rL-A9-DOX被开发用于准HER2阳性乳腺癌. 这种结合物证明了选择性的癌细胞杀死和有效的细胞吸收,提供了一个有希望的向治疗方法.
科学领域:
- 在瘤学瘤学.
- 生物结合化学 生物结合化学
- 分子药理学分子药理学
背景情况:
- 乳腺癌是全球主要的健康问题,通常以HER2受体过度表达为特征.
- 目前的治疗方法可能会导致显著的非目标毒性,需要更精确的治疗策略.
研究的目的:
- 合成和表征一种-药物合物 (rL-A9-DOX),用于向HER2表达乳腺癌细胞的向输送.
- 评估结合物的疗效,选择性和细胞吸收机制.
主要方法:
- 使用SMCC链接器将rL-A9与多克索鲁比辛 (DOX) 结合.
- 通过质谱测量对联体的表征.
- 分子对接研究以评估与HER2受体的结合亲和力.
- 在体外细胞毒性测定使用HER2-阳性和HER2-阴性细胞系.
- 流细胞计和共聚焦显微镜用于细胞内化研究.
主要成果:
- 与未结合的相比,rL-A9-DOX结合体对HER2受体的结合增强.
- 结合剂在HER2-阳性细胞 (SKOV3) 中表现出明显更高的细胞毒性,而不是在HER2-阴性细胞 (MDA-MB-231) 中.
- 流细胞计和共聚焦显微镜证实RL-A9-DOX结合物的有效细胞内化和核积累.
结论:
- 合成的rL-A9-DOX联合体是针对乳腺癌向治疗的有希望的候选者.
- 这种有针对性的方法最大限度地减少了非目标效应,并增强了向癌细胞的药物输送.
- 需要进一步的研究来探索这种新-药物合物的临床潜力.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K